Under the terms of the Distribution Agreement, Dilon will continue to manufacture the Product from its current manufacturing location in France and will supply and sell the Product to Xtant at a spec…
In 2025, we recognized $20.3 million in revenue from sales of our Coflex and CoFix products and international hardware products which we sold to Companion Spine.
We have biologics contracts with major GPOs, including Vizient, Premier, and HealthTrust Purchasing Group, as well as extensive access to IDNs across the United States for both biologics and spine ha…
We have biologics contracts with major GPOs, including Vizient, Premier, and HealthTrust Purchasing Group, as well as extensive access to IDNs across the United States for both biologics and spine ha…
Xtant Medical Holdings, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
XTNT-DEBT-13700
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-10-02.
XTNT-DEBT-13699
Warrants outstanding: 3500000
90%
xbrl warrant detail from xbrl 2023-03-31.
XTNT-DEBT
Debt stack $28.7M
90%
Market cache reports total debt of $28.7M.
Xtant Medical Holdings, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Xtant Medical Holdings, Inc..
Xtant Medical Holdings, Inc. Ownership
Holder
Name
Confidence
Evidence
XTNT-OWNER-NANTAHALA-CAPITAL-MANAGEMENT-LLC
Nantahala Capital Management, LLC
90%
13F overlay lists Nantahala Capital Management, LLC as top holder; 35 tracked holders.
Xtant Medical Holdings, Inc. Extended Supply Chain Network